Volker Kraft

Title: Volker Kraft: Innovator in Pharmaceutical Chemistry

Introduction

Volker Kraft is a distinguished inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of seven patents. His work primarily focuses on compounds that target the sodium-calcium exchanger, which plays a crucial role in various cardiovascular disorders.

Latest Patents

Kraft's latest patents include innovative compounds such as substituted chroman-6-yloxy-cycloalkanes and substituted 2-(chroman-6-yloxy)-thiazoles. The first patent describes these compounds as inhibitors of the sodium-calcium exchanger (NCX), particularly subtype 1 (NCX1). These compounds are designed for the treatment of disorders where intracellular calcium homeostasis is disrupted, including arrhythmias, heart failure, and stroke. The patent also outlines processes for preparing these compounds and their pharmaceutical applications. Similarly, the second patent focuses on thiazoles that share the same therapeutic potential and applications.

Career Highlights

Volker Kraft is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to further his research and development in pharmaceuticals, contributing to advancements in treatments for critical health issues.

Collaborations

Kraft has collaborated with notable colleagues such as Kai Rossen and Gerhard Kretzschmar. These partnerships have enhanced his research efforts and have been instrumental in the development of his patented compounds.

Conclusion

Volker Kraft's innovative work in pharmaceutical chemistry has led to significant advancements in the treatment of cardiovascular disorders. His contributions through patents and collaborations continue to impact the field positively.